CYTK

Cytokinetics, Incorporated News Headlines

$4.6
*  
0.31
7.23%
Get CYTK Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Good News for Nymox's Pipeline - Analyst Blog
3/21/2013 6:23:03 PM - Zacks.com

ISIS Presents Promising Data - Analyst Blog
3/21/2013 4:29:03 PM - Zacks.com

SGEN Seeks Adcetris Label Expansion - Analyst Blog
3/19/2013 7:15:01 PM - Zacks.com

DGX to Launch Dementia Test Panel - Analyst Blog
3/19/2013 6:44:59 PM - Zacks.com

Affymax to Cut 75% of Workforce - Analyst Blog
3/19/2013 5:45:01 PM - Zacks.com

New Data on Biogen/Elan's Tysabri - Analyst Blog
3/19/2013 4:44:21 PM - Zacks.com

SPPI Acquires Late-Stage Candidate - Analyst Blog
3/18/2013 6:45:44 PM - Zacks.com

Theravance Inks Deal for Vibativ - Analyst Blog
3/18/2013 4:44:02 PM - Zacks.com

DGX Supports Chronic Kidney Guide - Analyst Blog
3/15/2013 7:43:55 PM - Zacks.com

BioLineRx to Initiate HCV Study - Analyst Blog
3/15/2013 4:45:23 PM - Zacks.com

AmSurg Maintained at Neutral - Analyst Blog
3/15/2013 12:43:57 PM - Zacks.com

Genomic Health Reveals Positive Results - Analyst Blog
3/14/2013 5:47:59 PM - Zacks.com

Encouraging Results on ISIS Drug - Analyst Blog
3/14/2013 5:47:39 PM - Zacks.com

Loss at OREX Narrower than Expected - Analyst Blog
3/14/2013 5:45:16 PM - Zacks.com

Thermo Fisher Maintained at Neutral - Analyst Blog
3/14/2013 3:11:58 PM - Zacks.com

XOMA Posts Narrower Loss - Analyst Blog
3/14/2013 1:16:51 PM - Zacks.com

Lower Loss at Geron - Analyst Blog
3/14/2013 12:11:12 PM - Zacks.com

Peregrine Reports Narrower Loss - Analyst Blog
3/13/2013 6:14:18 PM - Zacks.com

Spectrum Guides Lower 2013 Revenue - Analyst Blog
3/13/2013 4:11:54 PM - Zacks.com

Biogen Files Hemophilia B Application - Analyst Blog
3/13/2013 4:09:18 PM - Zacks.com

Threshold Cuts Loss, Misses Sales - Analyst Blog
3/13/2013 9:10:16 AM - Zacks.com

Major Setback for Aeterna Zentaris - Analyst Blog
3/12/2013 7:13:03 PM - Zacks.com

PDLI Guides Q1 Royalty Revenue - Analyst Blog
3/12/2013 5:13:21 PM - Zacks.com

Update on Elan's Plans - Analyst Blog
3/11/2013 5:08:47 PM - Zacks.com

Acorda Presents GGF2 Data - Analyst Blog
3/8/2013 5:15:01 PM - Zacks.com